These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 34864927)

  • 1. Gastroenteropancreatic Neuroendocrine Neoplasms in Patients with Inflammatory Bowel Disease: An ECCO CONFER Multicentre Case Series.
    Festa S; Zerboni G; Derikx LAAP; Ribaldone DG; Dragoni G; Buskens C; van Dijkum EN; Pugliese D; Panzuto F; Krela-Kaźmierczak I; Mintz HR; Shitrit AB; Chaparro M; Gisbert JP; Kopylov U; Teich N; Vainer E; Nagtegaal I; Hoentjen F; Garcia MJ; Filip R; Foteinogiannopoulou K; Koutroubakis IE; Argollo M; van Wanrooij RLJ; Laja H; Lobaton T; Truyens M; Molnar T; Savarino E; Aratari A; Papi C; Goren I
    J Crohns Colitis; 2022 Jul; 16(6):940-945. PubMed ID: 34864927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gastroenteropancreatic neuroendocrine neoplasms: a 10-year experience of a single center.
    Lewkowicz E; Trofimiuk-Müldner M; Wysocka K; Pach D; Kiełtyka A; Stefańska A; Sowa-Staszczak A; Tomaszewska R; Hubalewska-Dydejczyk A
    Pol Arch Med Wewn; 2015; 125(5):337-46. PubMed ID: 25924181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent epidemiology of patients with gastro-entero-pancreatic neuroendocrine neoplasms (GEP-NEN) in Japan: a population-based study.
    Masui T; Ito T; Komoto I; Uemoto S;
    BMC Cancer; 2020 Nov; 20(1):1104. PubMed ID: 33189127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathological features and prognosis of gastroenteropancreatic neuroendocrine neoplasms in a Chinese population: a large, retrospective single-centre study.
    Zhang M; Zhao P; Shi X; Zhao A; Zhang L; Zhou L
    BMC Endocr Disord; 2017 Jul; 17(1):39. PubMed ID: 28705205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiological Data and Treatment of Gastroenteropancreatic Neuroendocrine Neoplasms: Insights From Tertiary Referral Hospitals in Latvia.
    Ptasnuka M; Ozolins A; Narbuts Z; Truskovs A; Sperga M; Plaudis H
    World J Surg; 2020 Feb; 44(2):585-593. PubMed ID: 31605174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Risk of Second Primary Colorectal Adenocarcinomas Is Not Increased among Patients with Gastroenteropancreatic Neuroendocrine Neoplasms: A Nationwide Population-Based Study.
    Stemann Lau T; Dam G; Jepsen P; Grønbæk H; Krogh K; Gregersen T
    Neuroendocrinology; 2018; 107(3):280-283. PubMed ID: 30092588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gastroenteropancreatic neuroendocrine neoplasms: epidemiology, genetics, and treatment.
    Tan B; Zhang B; Chen H
    Front Endocrinol (Lausanne); 2024; 15():1424839. PubMed ID: 39411312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathologic characteristics and prognosis of gastroenteropancreatic neuroendocrine neoplasms: a multicenter study in South China.
    Fang C; Wang W; Zhang Y; Feng X; Sun J; Zeng Y; Chen Y; Li Y; Chen M; Zhou Z; Chen J
    Chin J Cancer; 2017 Jun; 36(1):51. PubMed ID: 28637502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of sequence polymorphisms in the displacement loop region of mitochondrial DNA as a risk factor for gastroenteropancreatic neuroendocrine neoplasm.
    Er LM; Wu ML; Gao Y; Wang SJ; Li Y
    J Clin Lab Anal; 2017 Sep; 31(5):. PubMed ID: 27704598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiology of gastroenteropancreatic neuroendocrine neoplasms: a review and protocol presentation for bridging tumor registry data with the Italian association for neuroendocrine tumors (Itanet) national database.
    Panzuto F; Partelli S; Campana D; de Braud F; Spada F; Cives M; Tafuto S; Bertuzzi A; Gelsomino F; Bergamo F; Marcucci S; Mastrangelo L; Massironi S; Appetecchia M; Filice A; Badalamenti G; Bartolomei M; Amoroso V; Landoni L; Rodriquenz MG; Valente M; Colao A; Isidori A; Fanciulli G; Bollina R; Ciola M; Butturini G; Marconcini R; Arvat E; Cinieri S; Berardi R; Baldari S; Riccardi F; Spoto C; Giuffrida D; Gattuso D; Ferone D; Rinzivillo M; Bertani E; Versari A; Zerbi A; Lamberti G; Lauricella E; Pusceddu S; Fazio N; Dell'Unto E; Marini M; Falconi M
    Endocrine; 2024 Apr; 84(1):42-47. PubMed ID: 38175391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gastroenteropancreatic neuroendocrine neoplasms: current development, challenges, and clinical perspectives.
    Zhang XB; Fan YB; Jing R; Getu MA; Chen WY; Zhang W; Dong HX; Dakal TC; Hayat A; Cai HJ; Ashrafizadeh M; Abd El-Aty AM; Hacimuftuoglu A; Liu P; Li TF; Sethi G; Ahn KS; Ertas YN; Chen MJ; Ji JS; Ma L; Gong P
    Mil Med Res; 2024 Jun; 11(1):35. PubMed ID: 38835066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Site-specific trends in gastroenteropancreatic neuroendocrine neoplasms in Bavaria, Germany.
    Grundmann N; Voigtländer S; Hakimhashemi A; Pape UF; Meyer M; Müller-Nordhorn J
    Cancer Med; 2023 Oct; 12(19):19949-19958. PubMed ID: 37737059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An 11-year retrospective study: clinicopathological and survival analysis of gastro-entero-pancreatic neuroendocrine neoplasm.
    Liu H; Xie R; Zhao Z; Xu D; Yang K; Ding M; Tan D; Liao W; Han X; Zhang J; Shen D; Yuan J; Xu Z; Fei J
    Medicine (Baltimore); 2020 Aug; 99(33):e21682. PubMed ID: 32872039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Secondary malignancy in patients with sporadic neuroendocrine neoplasia.
    Krausch M; Raffel A; Anlauf M; Schott M; Lehwald N; Krieg A; Kröpil F; Cupisti K; Knoefel WT
    Endocrine; 2013 Oct; 44(2):510-6. PubMed ID: 23494366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical, pathological and prognostic characteristics of gastroenteropancreatic neuroendocrine neoplasms in China: a retrospective study.
    Zhang X; Ma L; Bao H; Zhang J; Wang Z; Gong P
    BMC Endocr Disord; 2014 Jul; 14():54. PubMed ID: 25001493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hereditary Colorectal Cancer Syndromes and Inflammatory Bowel Diseases: an ECCO CONFER Multicentre Case Series.
    Barberio B; Savarino E; Verstockt B; Fumery M; Pugliese D; Bertani L; Buda A; Dragoni G; Goren I; Laish I; Spinelli A; Teich N; Truyens M; Ellul P
    J Crohns Colitis; 2022 Dec; 16(12):1845-1852. PubMed ID: 35771951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An update on the diagnosis of gastroenteropancreatic neuroendocrine neoplasms.
    Fang JM; Li J; Shi J
    World J Gastroenterol; 2022 Mar; 28(10):1009-1023. PubMed ID: 35431496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs): a three-centric case-control study.
    Feola T; Puliani G; Sesti F; Modica R; Centello R; Minotta R; Cannavale G; Di Meglio S; Di Vito V; Lauretta R; Appetecchia M; Colao A; Lenzi A; Isidori AM; Faggiano A; Giannetta E
    J Endocrinol Invest; 2022 Apr; 45(4):849-857. PubMed ID: 35040099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics and treatment results of patients with gastroenteropancreatic neuroendocrine tumors in a tertiary care centre.
    Bazarbashi S; Aseafan M; Elgazzar T; Alkhayat M; Alghabban A; Abdelgawad MI; Alshamsan B; Alshibany A; Elhassan T; Aljubran A; Alzahrani A; Alhindi H; Raef H
    BMC Endocr Disord; 2023 Apr; 23(1):74. PubMed ID: 37029347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gastroenteropancreatic neuroendocrine neoplasms: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
    Pavel M; Öberg K; Falconi M; Krenning EP; Sundin A; Perren A; Berruti A;
    Ann Oncol; 2020 Jul; 31(7):844-860. PubMed ID: 32272208
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.